PREVENTT: Preoperative intravenous iron to treat anaemia in major surgery: Study protocol for a randomised controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  Richards, Toby ^a   Clevenger, Ben ^a,f   Keidan, Jane ^b   Collier, Tim ^c   Klein, Andrew A ^d   Anker, Stefan D ^e   Kelly, John D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Queen Elizabeth Hospital King's Lynn NHS Trust   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d PAPWORTH HOSPITAL   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Anaemia; Blood transfusion; Clinical trial; Intravenous iron; Patient blood management; Surgery

Indexed keywords

FERRIC CARBOXYMALTOSE; PLACEBO; ANTIANEMIC AGENT; BIOLOGICAL MARKER; FERRIC ION; HEMOGLOBIN; MALTOSE;

ABDOMINAL DISEASE; ABDOMINAL SURGERY; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; HEALTH CARE UTILIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR SURGERY; PARALLEL DESIGN; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT INDICATION; ABDOMEN; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONVALESCENCE; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; ENGLAND; HEALTH CARE PLANNING; HOSPITAL COST; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; SURGERY; TIME FACTOR; TREATMENT OUTCOME; UTILIZATION;

ABDOMEN; ADMINISTRATION, INTRAVENOUS; ANEMIA; BIOMARKERS; BLOOD TRANSFUSION; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRUG COSTS; ENGLAND; FERRIC COMPOUNDS; HEALTH RESOURCES; HEMATINICS; HEMOGLOBINS; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALTOSE; PREOPERATIVE CARE; RECOVERY OF FUNCTION; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84935019508     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0774-2     Document Type: Article

References (32)

1. World Health Organization. Nutritional Anaemias: report of a WHO Scientific Group (meeting held in Geneva from 13 to 17 March 1967). Geneva: World Health Organization; 1968.
2. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology. 2010;113:482-95.
3. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med. 2004;116:58-69.
4. Musallam KM, Tamim HA, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011;378:1396-407.
5. Hung M, Ortmann E, Besser M, Martin-Cabrera P, Richards T, Ghosh M, et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. Heart. 2015;101:2. 107-112.
6. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-23.
7. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-6.
8. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion. 2007;47:1468-80.
9. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM. Perioperative anemia: an independent risk factor for infection, mortality and resource utilization in surgery. J Surg Res. 2002;102:237-44.
10. Leichtle SW, Mouawad NJ, Lampman R, Singal B, Cleary RK. Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg. 2011;212:187-94.
11. National Clinical Guideline Centre (UK). Anaemia Management in Chronic Kidney Disease: Rapid Update 2011. London: Royal College of Physicians (UK); 2011.
12. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545-53.
13. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436-48.
14. Theusinger OM, Leyvraz P-F, Schanz U, Seifert B, Spahn DR. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology. 2007;107:923-7.
15. Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res. 2012;39:504-10.
16. Cuenca J, García-Erce JA, Muñoz M, Izuel M, Martínez AA, Herrera A. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion. 2004;44:1447-52.
17. Serrano-Trenas JA, Ugalde PF, Cabello LM, Chofles LC, Lázaro PS, Benítez PC. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion. 2011;51:97-104.
18. Kim YH, Chung HH, Kang S-B, Kim SC, Kim YT. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. Acta Haematol. 2009;121:37-41.
19. Díez-Lobo AI, Fisac-Martín MP, Bermejo-Aycar I, Muñoz M. Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy. Transfus Altern Transfus Med. 2007;9:114-9.
20. Garcia-Erce JA, Cuenca J, Munoz M, Izuel M, Martinez AA, Herrera A, et al. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang. 2005;88:235-43.
21. Auerbach M, Goodnough LT, Picard D, Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion. 2008;48:988-1000.
22. Beris P, Munoz M, Garcia-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth. 2008;100:599-604.
23. Nieboer TE, Johnson N, Lethaby A, Tavender E, Curr E, Garry R, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2009;3:CD003677.
24. Medeiros LRF, Rosa DD, Bozzetti MC, Fachel JMG, Furness S, Garry R, et al. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev. 2009;2:CD004751.
25. Ahmed Ali U, Keus F, Heikens JT, Bemelman WA, Berdah SV, Gooszen HG, et al. Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis. Cochrane Database Syst Rev. 2009;1.
26. Grocott MPW, Browne JP, Van der Meulen J, Matejowsky C, Mutch M, Hamilton MA, et al. The Postoperative Morbidity Survey was validated and used to describe morbidity after major surgery. J Clin Epidemiol. 2007;60:919-28.
27. Department of Health (UK). Delivering Enhanced Recovery - Helping Patients to get Better Sooner after Surgery: Best Practice Guidance 2010. London: Department of Health (UK); 2010.
28. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. Eur J Heart Fail. 2009;11:1084-91.
29. Ponikowski P, van Veldhuisen DJ, Comin Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36:657-68.
30. Hofmann A, Farmer S, Shander A. Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management. Oncologist. 2011;16:3-11.
31. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453-62.
32. Carson JL, Carless PA, Hébert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.